Eli Lilly (LLY) PT Raised to $580 at Credit Suisse
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,255.40 +0.88%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Credit Suisse analyst Trung Huynh raised the price target on Eli Lilly (NYSE: LLY) to $580.00 (from $490.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
- AAC Technologies Holdings Inc. (2018:HK) (AACAY) PT Raised to HK$55.50 at Macquarie
- A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
